bpc-157 fda warning 2025 october On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval BPC-157 and the Difference Between

This product is intended solely for research purposes and is not for human consumption

Support for normal energy levels and reduced tiredness Support for concentration and mental clarity Support for mood and general wellbeing Support for healthy red blood cell production Support for the nervous system and immune system Results vary from person to person, and treatment is not a substitute for further medical assessment where needed

A peptide that varies in potency between batches can produce fluctuating hormone levels and unclear outcomes

WADA added it to the Prohibited List in 2022, category S0

They support the bodys existing metabolic processes

[DOI] [PMC free article] [PubMed] [Google Scholar] 21.Gojkovic S., Krezic I., Vranes H., Zizek H., Drmic D., Vuletic L.B., Milavic M., Sikiric S., Stilinovic I., Simeon P., et al